PBE holdings

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	ILMNIllumina Inc	Equity	6.15%	$25M	95,399	US
2	NTRANatera, Inc. Common Stock	Equity	6.07%	$25M	63,745	US
3	BIIBBiogen Inc. Common Stock	Equity	5.17%	$21M	97,223	US
4	GILDGilead Sciences Inc	Equity	5.17%	$21M	144,274	US
5	AMGNAmgen Inc	Equity	4.82%	$20M	48,534	US
6	VRTXVertex Pharmaceuticals Inc	Equity	4.76%	$20M	38,824	US
7	RPRXRoyalty Pharma plc Class A Ordinary Shares	Equity	4.74%	$19M	345,798
8	REGNRegeneron Pharmaceuticals Inc	Equity	4.64%	$19M	25,749	US
9	MRNAModerna, Inc. Common Stock	Equity	3.54%	$15M	73,715	US
10	NVAXNovavax Inc	Equity	3.33%	$14M	1,240,199	US
11	EXELExelixis Inc	Equity	2.97%	$12M	206,408	US
12	UTHRUnited Therapeutics Corp	Equity	2.93%	$12M	22,579	US
13	QGENQIAGEN N.V.	Equity	2.91%	$12M	268,212
14	HALOHalozyme Therapeutics, Inc.	Equity	2.87%	$12M	107,094	US
15	VCYTVeracyte, Inc.	Equity	2.82%	$12M	265,837	US
16	SRPTSarepta Therapeutics,, Inc. Common Stock	Equity	2.75%	$11M	618,788	US
17	TGTXTG Therapeutics, Inc.	Equity	2.75%	$11M	211,250	US
18	PTGXProtagonist Therapeutics, Inc	Equity	2.65%	$11M	77,744	US
19	VCELVericel Corporation	Equity	2.64%	$11M	270,881	US
20	NBIXNeurocrine Biosciences Inc	Equity	2.63%	$11M	76,336	US
21	RGENRepligen Corp	Equity	2.57%	$11M	64,437	US
22	LEGNLegend Biotech Corporation American Depositary Shares	Cash	2.51%	$10M	549,646
23	INCYIncyte Genomics Inc	Equity	2.48%	$10M	90,252	US
24	ARDXArdelyx, Inc.	Equity	2.47%	$10M	3,097,216	US
25	PTCTPTC Therapeutics, Inc.	Equity	2.43%	$10.0M	159,351	US
26	BCRXBioCryst Pharmaceuticals Inc	Equity	2.41%	$9.9M	1,190,995	US
27	BMRNBioMarin Pharmaceuticals Inc	Equity	2.37%	$9.7M	177,064	US
28	COLLCollegium Pharmaceutical, Inc. Common Stock	Equity	2.30%	$9.4M	426,191	US
29	ANABAnaptysBio, Inc. Common Stock	Equity	2.26%	$9.3M	200,573	US
30	ACADAcadia Pharmaceuticals Inc.	Equity	1.83%	$7.5M	382,973	US
31	AGPXXInvesco Government & Agency Portfolio	Cash	0.08%	$343K	342,884
32	USDProShares Ultra Semiconductors	Cash	0.00%	$6K	5,728	US
33	SECURITIES LENDING - BNYM	Cash	0.00%	$0	1

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
Exit	FOLDAmicus Therapeutics, Inc.	3.90%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	DVAXDynavax Technologies Corp.	3.65%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	ARWRArrowhead Pharmaceuticals, Inc.	—	3.28%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	CDNACareDx, Inc.	—	3.07%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	TBPHTheravance Biopharma Inc.	—	2.50%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	MDGLMadrigal Pharmaceuticals, Inc.	2.24%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	ALNYAlnylam Pharmaceuticals, Inc.	3.85%	4.84%	+32.3%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	GILDGilead Sciences, Inc.	5.60%	4.62%	−14.0%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	VCYTVeracyte, Inc.	2.20%	2.62%	+32.7%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	AMGNAmgen Inc.	5.06%	4.71%	−11.5%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	RPRXRoyalty Pharma PLC	2.83%	3.13%	−11.2%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	BMRNBioMarin Pharmaceutical Inc.	2.75%	2.45%	−10.1%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	PTCTPTC Therapeutics, Inc.	2.55%	2.68%	+17.4%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	RGENRepligen Corp.	2.41%	2.50%	+26.0%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	TECHBio-Techne Corp.	2.72%	2.73%	+11.8%	Jan 31, 2026 → Apr 30, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.